JP2024508969A5 - - Google Patents
Info
- Publication number
- JP2024508969A5 JP2024508969A5 JP2023554812A JP2023554812A JP2024508969A5 JP 2024508969 A5 JP2024508969 A5 JP 2024508969A5 JP 2023554812 A JP2023554812 A JP 2023554812A JP 2023554812 A JP2023554812 A JP 2023554812A JP 2024508969 A5 JP2024508969 A5 JP 2024508969A5
- Authority
- JP
- Japan
- Prior art keywords
- repeat domain
- ankyrin repeat
- human
- binding specificity
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163158539P | 2021-03-09 | 2021-03-09 | |
| US63/158,539 | 2021-03-09 | ||
| US202163172818P | 2021-04-09 | 2021-04-09 | |
| US63/172,818 | 2021-04-09 | ||
| US202163265179P | 2021-12-09 | 2021-12-09 | |
| US63/265,179 | 2021-12-09 | ||
| PCT/IB2022/052120 WO2022190010A1 (en) | 2021-03-09 | 2022-03-09 | Novel darpin based cd33 engagers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508969A JP2024508969A (ja) | 2024-02-28 |
| JP2024508969A5 true JP2024508969A5 (enExample) | 2025-03-18 |
Family
ID=80933410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554812A Pending JP2024508969A (ja) | 2021-03-09 | 2022-03-09 | 新規のＤＡＲＰｉｎに基づくＣＤ３３エンゲージャ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240317852A1 (enExample) |
| EP (1) | EP4304730A1 (enExample) |
| JP (1) | JP2024508969A (enExample) |
| AU (1) | AU2022231913A1 (enExample) |
| CA (1) | CA3211248A1 (enExample) |
| WO (1) | WO2022190010A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240279290A1 (en) | 2020-05-14 | 2024-08-22 | Molecular Partners Ag | Multispecific proteins |
| BR112023018293A2 (pt) | 2021-03-09 | 2023-10-31 | Molecular Partners Ag | Acopladores de célula t multiespecíficos à base de darpin |
| EP4724460A1 (en) * | 2023-06-06 | 2026-04-15 | Molecular Partners AG | Recombinant cd16a binding proteins and their use |
| WO2025163083A1 (en) * | 2024-01-31 | 2025-08-07 | Molecular Partners Ag | Recobminant dll3 binding proteins and their use |
| WO2025181039A1 (en) | 2024-03-01 | 2025-09-04 | Molecular Partners Ag | Therapeutic combinations comprising a multi-specific t cell engager |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9400088D0 (sv) | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| EP1332209B1 (en) | 2000-09-08 | 2009-11-11 | Universität Zürich | Collections of repeat proteins comprising repeat modules |
| US20040175756A1 (en) | 2001-04-26 | 2004-09-09 | Avidia Research Institute | Methods for using combinatorial libraries of monomer domains |
| US20050053973A1 (en) | 2001-04-26 | 2005-03-10 | Avidia Research Institute | Novel proteins with targeted binding |
| US20050048512A1 (en) | 2001-04-26 | 2005-03-03 | Avidia Research Institute | Combinatorial libraries of monomer domains |
| WO2005063815A2 (en) | 2003-11-12 | 2005-07-14 | Biogen Idec Ma Inc. | Fcϝ receptor-binding polypeptide variants and methods related thereto |
| US20060008844A1 (en) | 2004-06-17 | 2006-01-12 | Avidia Research Institute | c-Met kinase binding proteins |
| US9365629B2 (en) | 2007-09-24 | 2016-06-14 | University Of Zurich | Designed armadillo repeat proteins |
| BRPI0921469B1 (pt) | 2008-11-03 | 2022-01-18 | Molecular Partners Ag | Proteínas de ligação que inibem a interação com o receptor de vegf-a, composição farmacêutica |
| EP2332994A1 (en) * | 2009-12-09 | 2011-06-15 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Trispecific therapeutics against acute myeloid leukaemia |
| AR081361A1 (es) | 2010-04-30 | 2012-08-29 | Molecular Partners Ag | Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a |
| PL2643349T3 (pl) | 2010-11-26 | 2020-03-31 | Molecular Partners Ag | Zaprojektowane białka z powtórzeniami wiążące się z albuminą surowicy |
| WO2014001442A1 (en) | 2012-06-28 | 2014-01-03 | Molecular Partners Ag | Designed ankyrin repeat proteins binding to platelet-derived growth factor |
| EP2738180A1 (en) | 2012-11-30 | 2014-06-04 | Molecular Partners AG | Binding proteins comprising at least two binding domains against HER2. |
| EP2789630A1 (en) | 2013-04-09 | 2014-10-15 | EngMab AG | Bispecific antibodies against CD3e and ROR1 |
| CN105209483B (zh) | 2013-05-31 | 2021-07-27 | 分子组合公司 | 与肝细胞生长因子结合的设计锚蛋白重复蛋白 |
| KR102427117B1 (ko) | 2015-04-02 | 2022-07-29 | 몰리큘라 파트너스 아게 | 혈청 알부민에 대한 결합 특이성을 갖는 설계된 안키린 반복 도메인 |
| CN109790206A (zh) | 2016-09-22 | 2019-05-21 | 分子组合公司 | 重组结合蛋白及其用途 |
-
2022
- 2022-03-09 US US18/281,156 patent/US20240317852A1/en active Pending
- 2022-03-09 WO PCT/IB2022/052120 patent/WO2022190010A1/en not_active Ceased
- 2022-03-09 AU AU2022231913A patent/AU2022231913A1/en not_active Abandoned
- 2022-03-09 CA CA3211248A patent/CA3211248A1/en active Pending
- 2022-03-09 JP JP2023554812A patent/JP2024508969A/ja active Pending
- 2022-03-09 EP EP22712451.8A patent/EP4304730A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024508969A5 (enExample) | ||
| JP2024509241A5 (enExample) | ||
| JP2024513559A5 (enExample) | ||
| JP2023179436A5 (enExample) | ||
| JP2016052315A5 (enExample) | ||
| JP2019531093A5 (enExample) | ||
| JP2023506765A5 (enExample) | ||
| JP2025137626A5 (enExample) | ||
| JP2021502810A5 (enExample) | ||
| JP2024509904A5 (enExample) | ||
| JP2021521822A5 (enExample) | ||
| JP2013534812A5 (enExample) | ||
| JP2022527635A5 (enExample) | ||
| JP2018521640A5 (enExample) | ||
| JP2019511201A5 (enExample) | ||
| WO2021092075A1 (en) | IL-2RβγC BINDING COMPOUNDS | |
| JP2016516061A5 (enExample) | ||
| CA2561826A1 (en) | Linear single chain recombinant anti-cea/cd3/cd28 trispecific antibody | |
| JP2023553697A5 (enExample) | ||
| JP2023123649A5 (enExample) | ||
| JP2023528204A5 (enExample) | ||
| JP2023554379A5 (enExample) | ||
| JP2023528207A5 (enExample) | ||
| JP2022524338A5 (enExample) | ||
| CN105142663A (zh) | 用于癌症靶向治疗的含有结合白蛋白的精氨酸脱亚胺酶的药物组合物 |